Crystalys Therapeutics, a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people living with gout, today announced that the first patients have been dosed at ...
While CagriSema bested Novo Nordisk's Wegovy on blood sugar control in a late-stage trial, the next-gen weight loss drug still has not met the pharma's 25% weight loss goal.
Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa (DNL310) to address full disease spectrumLaunch readiness ...
Among adults with acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack (TIA) with planned ...
Africa’s renewable energy expansion is accelerating, led by solar deployment across East, West, and Southern Africa. Yet as ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...
The Defence Research and Development Organisation (DRDO) on Tuesday successfully conducted a flight test of its Solid Fuel Ducted Ramjet (SFDR) techn ...
As India’s cold chain market targets double-digit growth through 2028, the $5 billion quick-commerce boom is forcing a ...
New retrospective analysis showed Orca-T with reduced intensity conditioning (RIC) demonstrated favorable OS, RFS and GRFS compared to PTCyCompany announced first patients dosed in the Phase 2 ...
The Space Force pressed ahead with R-GPS using the funding it had, even after Congress declined to approve the additional $77 million. A year later, the dynamic has reversed: the Space Force says it ...
BFSI brands in 2026 are grappling with a digital-first and sceptical audience. In this story, BFSI leaders break down the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results